5 completed. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
Follow Santen Oy: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations Timolol and Tafluprost, Fixed Dose Combination of tafluprost and timolol - Ocular Hypertension, Open-angle Glaucoma | Phase 3 | Completed | Santen Oy | 401 | 2011-03-01 | 2012-06-08 |
| Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies Timolol/ FDC/ Placebo/ Tafluprost - Ocular Hypertension, Open-angle Glaucoma | Phase 3 | Completed | Santen Oy | 600 | 2011-02-01 | 2013-03-13 |
| Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost to Preservative Free Tafluprost Eye Drops tafluprost - Ocular Hypertension, Open-Angle Glaucoma | Phase 3 | Completed | Santen Oy | 185 | 2010-04-01 | 2013-05-31 |
| Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops tafluprost - Ocular Hypertension, Open-Angle Glaucoma | Phase 3 | Completed | Santen Oy | 150 | 2008-01-01 | 2009-01-12 |
| Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation Tafluprost 0.0015% - Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Completed | Santen Oy | 43 | 2005-09-01 | 2010-12-28 |
Glaucoma, Open-Angle (5) · Ocular Hypertension (5)
tafluprost (4) · Timolol (2)
Finland (3) · Germany (1) · Hungary (1)
Auli Ropo, M.D. (2) · Clemens Vass, M.D. (1) · Eva Ruzickova, M.D. (1) · Evgeniy Egorov, Professor (1) · Guna Laganovska, M.D. (1) · Hannu Uusitalo, M.D., Prof. (1) · Hannu Uusitalo, Professor (1) · Juhani Airaksinen, Prof. (1) · Maria L. Ribeiro, M.D. (1) · Marieta Kostianeva, M.D. (1)